Recombinant Anti-CA72-4 x Anti-CD3 Bispecific Antibody (scFv4-Ig) (FVTIG-027)

Recombinant Anti-CA72-4 x Anti-CD3 Bispecific Antibody (scFv4-Ig) is an appended IgG format, which includes four scFv moieties at the N-termini of the constant regions. It is a bivalent homodimer, in which one anti-CA72-4 scFv is fused to the CH1 domain of a heavy chain and another anti-CD3 scFv to the CL domain of a light chain, or vice versa. The resulting leads to 2+2 antigen-binding valency. This BsAb can retarget T cells to tumor cells. It is designed for the research of Gastrointestinal cancer; Ovarian cancer; Colon cancer; Gastric cancer; Breast cancer; Adenocarcinomas therapy.

Datasheet INQUIRY

Specifications

Targets

CA72-4 & CD3

Type

Appended IgGs

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Gastrointestinal cancer; Ovarian cancer; Colon cancer; Gastric cancer; Breast cancer; Adenocarcinomas

Targets

Target 1

CA72-4

Alternative Names

CA72-4; Cancer antigen 72-4; Carbohydrate antigen 72-4

Target 2

CD3

Gene ID

916

UniProt ID

P07766

Alternative Names

CD3; CD3E; CD3e molecule; Cluster of differentiation 3; CD3e molecule, epsilon (CD3-TCR complex); T3E; TCRE; IMD18; T-cell surface glycoprotein CD3 epsilon chain; CD3-epsilon; T-cell surface antigen T3/Leu-4 epsilon chain; CD3e antigen, epsilon polypeptide (TiT3 complex); T-cell antigen receptor complex, epsilon subunit of T3

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CA72-4 x Anti-CD3 Bispecific Antibody (scFv4-Ig) (FVTIG-027). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CA72-4 x Anti-CD3 Bispecific Antibody (scFv4-Ig) (CAT#: FVTIG-027)

Specifications

Targets

Customer Reviews and Q&As